Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
133.67
+0.78 (0.59%)
Dec 20, 2024, 4:00 PM EST - Market closed

Integer Holdings Revenue

Integer Holdings had revenue of $431.42M in the quarter ending September 27, 2024, with 8.72% growth. This brings the company's revenue in the last twelve months to $1.71B, up 12.41% year-over-year. In the year 2023, Integer Holdings had annual revenue of $1.60B with 16.03% growth.

Revenue (ttm)
$1.71B
Revenue Growth
+12.41%
P/S Ratio
2.62
Revenue / Employee
$163,107
Employees
10,500
Market Cap
4.48B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.60B220.58M16.03%
Dec 31, 20221.38B155.02M12.70%
Dec 31, 20211.22B147.64M13.75%
Dec 31, 20201.07B-184.65M-14.68%
Dec 31, 20191.26B43.08M3.55%
Dec 28, 2018 Pro Pro Pro
Dec 29, 2017 Pro Pro Pro
Dec 30, 2016 Pro Pro Pro
Jan 1, 2016 Pro Pro Pro
Jan 2, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alkermes 1.51B
Apellis Pharmaceuticals 715.22M
ADMA Biologics 382.81M
Axsome Therapeutics 338.46M
TG Therapeutics 264.79M
Krystal Biotech 241.52M
BridgeBio Pharma 217.77M
PROCEPT BioRobotics 199.84M
Revenue Rankings